Huelsboemer Lioba, Boroumand Sam, Boroumand Tara, Vafa Aliyar Zahedi, Parikh Neil, Chiarella Laetitia S, Knoedler Leonard, Stögner Viola A, Hung Peter, Sadigh Sam, Haykal Siba, Pomahac Bohdan, Kauke-Navarro Martin
Yale School of Medicine, Division of Reconstructive and Plastic Surgery, New Haven, CT, USA.
Yale School of Medicine, Division of Reconstructive and Plastic Surgery, New Haven, CT, USA; University of California, San Francisco School of Dentistry, San Francisco, CA, USA.
J Plast Reconstr Aesthet Surg. 2025 Feb;101:220-230. doi: 10.1016/j.bjps.2024.11.025. Epub 2024 Nov 25.
The long-term stability of allograft or native bone in facial vascularized composite allograft (fVCA) recipients is unclear. This study quantified long-term bone volume changes in facial transplants.
Computed tomography scans of eight fVCA recipients (2011-2023) were analyzed with Materialise Mimics. Native bone (soft tissue-only VCAs, n=4) and allotransplanted bone (n=4) were compared. Median bone volumes were assessed for significance using the WilcoxonRanked-Sum Test.
Mean follow-up was 10 years (range 5-13). A significant median decrease in both mandibular (-6520 mm; p=0.0078) and maxillary (-3548 mm; p=0.0078) bone volumes was seen in all patients, irrespective of bone origin. Median bone volume loss was -9.92% in the bony allograft cohort and -22.60% in the soft tissue-only cohort, respectively. The histopathological analysis of the limited samples (n=2) showed physiological bone even after ten years.
Patients with allotransplanted bone showed less pronounced volume loss compared to those with native bone receiving soft tissue-only allografts. This finding suggests that allotransplanted vascularized bone in fVCAs may not be a primary target of chronic rejection processes that compromise bone volume stability and functionality. Bone volume changes are likely influenced by multiple factors, such as tooth loss, nutrition, chronic immunosuppression (e.g., steroids), mechanical stress/load, varying bone remodeling rates, and other medical comorbidities. Further research is needed to clarify the factors affecting bone volume and remodeling after fVCA.
面部血管化复合组织异体移植(fVCA)受者同种异体骨或自体骨的长期稳定性尚不清楚。本研究对面部移植中的长期骨体积变化进行了量化。
使用Materialise Mimics分析了8例fVCA受者(2011 - 2023年)的计算机断层扫描。比较了自体骨(仅软组织VCA,n = 4)和同种异体移植骨(n = 4)。使用Wilcoxon秩和检验评估中位骨体积的显著性。
平均随访时间为10年(范围5 - 13年)。所有患者的下颌骨(-6520 mm;p = 0.0078)和上颌骨(-3548 mm;p = 0.0078)骨体积均出现显著的中位减少,与骨的来源无关。骨同种异体移植组的中位骨体积损失分别为-9.92%,仅软组织组为-22.60%。有限样本(n = 2)的组织病理学分析显示,即使在十年后仍为生理性骨。
与接受仅软组织同种异体移植的自体骨患者相比,同种异体移植骨患者的体积损失不太明显。这一发现表明,fVCA中同种异体移植的血管化骨可能不是损害骨体积稳定性和功能的慢性排斥过程的主要靶点。骨体积变化可能受多种因素影响,如牙齿缺失、营养、慢性免疫抑制(如类固醇)、机械应力/负荷、不同的骨重塑率以及其他合并症。需要进一步研究以阐明影响fVCA后骨体积和重塑的因素。